European Clinical Supply Planning – Balancing Cost, Flexibility and Time
Summary: Where is the optimal location to base the packaging and distribution of clinical supplies? This is a question that trial sponsors have been asking for decades. The simple answer is….it depends. The more actionable answer requires examining key study factors that can have a direct influence on clinical supply placement in conjunction with business decision drivers, preferences and even the study drug itself. The real answer is there is no single right country that will be perfect for every sponsor or every clinical trial, but there are ways to evaluate and narrow down the choices to get to the best option.
In this summary, a clinical supply management expert takes the audience on a tour of Europe. There are two major choices in Europe – countries in the European Union (EU) and those that are geographically in Europe but not part of EU, such as the UK. By the end, you can expect to have a better understanding of how to objectively evaluate and ultimately decide whether it is the EU or the UK that best aligns with your clinical supply strategy.